By Joe Elia An inhaled dual phosphodiesterase inhibitor, RPL554, shows promise against asthma and chronic obstructive pulmonary disease in a series of preliminary studies in the Lancet Respiratory Medicine. Inhibiting phosphodiesterases 3 and 4 would, in theory, both...
(BPT) – Actress Rose McGowan, best known for her leading role in the TV series, Charmed, is sharing her story in a new leading role: raising awareness for idiopathic pulmonary fibrosis, or IPF. After her father was diagnosed with IPF, she became determined to...
Scientists have developed a new drug (RPL554) that could treat obstructive airway diseases such as asthma and chronic obstructive pulmonary disease (COPD) in two ways at once, according to new research published in The Lancet Respiratory Medicine. RPL554 has the...
Executives Mike Aguiar – SVP and CFO Rick Winningham – CEO Analysts Steve Byrne – BofA Merrill Lynch David Friedman – Morgan Stanley Anant Padmanabhan – Cowen and Company Brian Skorney – Robert W. Baird & Company, Inc. Howard Liang – Leerink Swann & Company...
Newswise — Obstructive sleep apnea is known to be associated with an increased incidence of cardiovascular disease. Now a new study indicates that OSA is associated with subclinical myocardial injury, as indicated by increased high sensitivity troponin T (hs-TnT)...
Tags by: Richard K. Albert, John Connett, William C. Bailey, Richard Casaburi, J. Allen Cooper, Gerard J. Criner, Jeffrey L. Curtis, Mark T. Dransfield, Meilan K. Han, Stephen C. Lazarus, Barry Make, Nathaniel Marchetti, Fernando J. Martinez, Nancy E. Madinger,...
RSS Error: A feed could not be found at `http://www.scoop.it/t/pulmonaryrehabnews/rss.xml`; the status code is `404` and content-type is `text/html;charset=UTF-8`
